[Study of neurological and cognitive changes in patients in stage III and initial phases of stage IV of infection by human immunodeficiency virus type 1].
J Abós(Hospital Clínic de Barcelona), Eva Tolosa(Universitat Autònoma de Barcelona), Gabriel Marques(World Health Organization), Josep Mallolas(Hospital Clínic de Barcelona), Jordi Alom, Josep M. Miró(Hospital Clínic de Barcelona), Francesc Graus(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer)
PubMed
January 18, 1992
Cited by 0
Related Papers
A clinical approach to diagnosis of autoimmune encephalitis
|The Lancet Neurology|2016|4.4k
Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study
|The Lancet Neurology|2013|3.1k
Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series
|The Lancet Neurology|2010|1.4k
Antibody-Mediated Encephalitis
|New England Journal of Medicine|2018|1.3k
Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study
|The Lancet Neurology|2013|1.3k